pubmed.ncbi.nlm.nih.gov
Clinical, gut microbial and neural effects of a probiotic add-on therapy in depressed patients: a randomized controlled trial - PubMed
A promising new treatment approach for major depressive disorder (MDD) targets the microbiota-gut-brain (MGB) axis, which is linked to physiological and behavioral functions affected in MDD. This is the first randomized controlled trial to determine whether short-term, high-dose probiotic supplement …